• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Alessandro Cignetti, Eileen Bryant, Bernardino Allione, Alessandro Vitale, Robin Foà, Martin A Cheever
  • Biology, Medicine
  • Blood
  • 1999 (First Publication: 15 September 1999)
  • CD34(+) hematopoietic stem cells from normal individuals and from patients with chronic myelogenous leukemia can be induced to differentiate into dendritic cells (DC). The aim of the current studyExpand
  • Dario Sangiolo, Emanuela Martinuzzi, +10 authors Alessandro Cignetti
  • Biology, Medicine
  • International immunology
  • 2008 (First Publication: 1 July 2008)
  • Donor-derived cytokine-induced killer (CIK) can be infused as adoptive immunotherapy after hematopoietic cell transplant (HCT). Promising results were recently reported in HLA-identical HCT, whereExpand
  • A. Cignetti, A. Vallario, +5 authors F. Caligaris-Cappio
  • Biology, Medicine
  • The Journal of Immunology
  • 2004 (First Publication: 15 August 2004)
  • Primary acute myeloid leukemia cells can be induced to differentiate into dendritic cells (DC). In the presence of GM-CSF, TNF-α, and/or IL-4, leukemia-derived DC are obtained that display featuresExpand
  • Dario Sangiolo, Giulia Mesiano, Fabrizio Carnevale-Schianca, Wanda Piacibello, Massimo Aglietta, Alessandro Cignetti
  • Medicine
  • Expert opinion on biological therapy
  • 2009 (First Publication: 1 July 2009)
  • Donor lymphocyte infusion (DLI) is used to increase the graft versus tumor (GVT) effect after allogeneic hematopoietic cell transplant (HCT). The limited spectrum of activity and high risk of graftExpand
  • F. Carnevale-Schianca, A. Cignetti, +18 authors M. Aglietta
  • Medicine
  • Blood
  • 2006 (First Publication: 1 May 2006)
  • A pilot study was conducted to evaluate safety and activity of nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) in colorectal carcinoma (CRC) and to determine whether a T-cellExpand